---
title: 心律异常
description: 
---

[◀返回](./home.md)

# 心律异常

**心律异常**（也称为**心律不齐**）被定义为心跳速率或节律的问题呢。[\[1\]](#cite_note-1) 心跳过快（每分钟超过 100 次）被称为*心动过速*，心跳过慢（每分钟少于 60 次）被称为*心动过缓*。心律失常是由心脏组织的变化引起的。心脏跳动是由级联电信号引起的，这些信号可能会受到压力荷尔蒙、电解质和药物物质的影响哦。

心律异常最常见于服用[中等](/文档/给药剂量.md#中等)[剂量](/文档/给药剂量.md)的[兴奋剂](/文档/药物分类/兴奋剂.md)和[抑制剂](/文档/药物分类/抑制剂.md)类化合物时，如[可卡因](/药物/可卡因.md)、[\[2\]](#cite_note-2)[\[3\]](#cite_note-3)[\[4\]](#cite_note-4)[\[5\]](#cite_note-5)[\[6\]](#cite_note-6)[\[7\]](#cite_note-7)[\[8\]](#cite_note-8) [苯丙胺类物质](/文档/药物分类/苯丙胺类物质.md)、[\[9\]](#cite_note-9)[\[10\]](#cite_note-10)[\[11\]](#cite_note-11)[\[12\]](#cite_note-12)[\[13\]](#cite_note-:0-13) [酒精](/药物/酒精.md)、[\[13\]](#cite_note-:0-13) 和[阿片类药物](/文档/药物分类/阿片类药物.md)。[\[13\]](#cite_note-:0-13)[\[14\]](#cite_note-14)[\[15\]](#cite_note-15) 虽然[兴奋剂](/文档/药物分类/兴奋剂.md)倾向于增加一个人的心率，而[抑制剂](/文档/药物分类/抑制剂.md)倾向于降低心率。将两者[联用](/文档/危险药物联用.md)通常会导致危险的不规则心跳呢。

### 目录

*   [1 精神活性物质](#精神活性物质)
*   [2 体验报告](#体验报告)
*   [3 另见](#另见)
*   [4 外部链接](#外部链接)
*   [5 参考文献](#参考文献)

<!-- 请勿删除或修改，这是一个标记，待识别并填坑（药效索引） -->

### 体验报告

在我们的[体验报告](/报告/psychounautwiki/)中，描述了这种效应的轶事报告包括：

*   [Experience: 550mg DPH - My First Time on DPH](/报告/psychounautwiki/Experience:_550mg_DPH_-_My_First_Time_on_DPH)
*   [Experience:800-900mg Ephenidine + unknown quantity flubroalzolam - Multiday Insanity](/报告/psychounautwiki/Experience:800-900mg_Ephenidine_%2B_unknown_quantity_flubroalzolam_-_Multiday_Insanity)
*   [Experience:Clonazolam + 2-methyl-AP-237 (unknown dosage) - Cardiac arrest](/报告/psychounautwiki/Experience:Clonazolam_%2B_2-methyl-AP-237_(unknown_dosage)_-_Cardiac_arrest)
*   [Experience:Unknown dosage / 3 tabs - Ego death and a total break through in the snow](/报告/psychounautwiki/Experience:Unknown_dosage_/_3_tabs_-_Ego_death_and_a_total_break_through_in_the_snow)

### 另见

*   [负责任的用药](/文档/负责任的用药索引页.md)
*   [主观效应索引](/药效/home.md)
*   [迷幻剂 - 主观效应](/文档/药物分类/迷幻剂.md#主观效应)
*   [解离剂 - 主观效应](/文档/药物分类/解离剂.md#主观效应)
*   [谵妄剂 - 主观效应](/文档/药物分类/谵妄剂.md#主观效应)

### 外部链接

*   [心律失常 (维基百科)](https://en.wikipedia.org/wiki/Heart_arrhythmia)

### 参考文献

1.  [↑](#cite_ref-1) [*Arrhythmias - What Is an Arrhythmia?*](https://www.nhlbi.nih.gov/health/arrhythmias), National Heart, Lung and Blood Institute, retrieved 4 June 2022 
2.  [↑](#cite_ref-2) Wood, D. M., Dargan, P. I., Hoffman, R. S. (January 2009). ["Management of cocaine-induced cardiac arrhythmias due to cardiac ion channel dysfunction"](http://www.tandfonline.com/doi/full/10.1080/15563650802339373). *Clinical Toxicology*. **47** (1): 14–23.
3.  [↑](#cite_ref-3) O’Leary, M. E., Hancox, J. C. (28 January 2010). ["Role of voltage-gated sodium, potassium and calcium channels in the development of cocaine-associated cardiac arrhythmias: Voltage-gated ion channels and cocaine-induced arrhythmia"](https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2125.2010.03629.x). *British Journal of Clinical Pharmacology*. **69** (5): 427–442.
4.  [↑](#cite_ref-4) Wood, D. M., Dargan, P. I. (28 January 2010). ["Putting cocaine use and cocaine-associated cardiac arrhythmias into epidemiological and clinical perspective: Cocaine epidemiology and cardiovascular toxicity"](https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2125.2010.03630.x). *British Journal of Clinical Pharmacology*. **69** (5): 443–447.
5.  [↑](#cite_ref-5) Gradman, A. H. (April 1988). "Cardiac effects of cocaine: a review". *The Yale Journal of Biology and Medicine*. **61** (2): 137–147.
6.  [↑](#cite_ref-6) Lange, R. A., Hillis, L. D. (2 August 2001). ["Cardiovascular Complications of Cocaine Use"](http://www.nejm.org/doi/abs/10.1056/NEJM200108023450507). *New England Journal of Medicine*. **345** (5): 351–358.
7.  [↑](#cite_ref-7) Tazelaar, H. D., Karch, S. B., Stephens, B. G., Billingham, M. E. (February 1987). ["Cocaine and the heart"](https://linkinghub.elsevier.com/retrieve/pii/S0046817787803386). *Human Pathology*. **18** (2): 195–199.
8.  [↑](#cite_ref-8) Maraj, S., Figueredo, V. M., Lynn Morris, D. (May 2010). ["Cocaine and the Heart"](https://onlinelibrary.wiley.com/doi/10.1002/clc.20746). *Clinical Cardiology*. **33** (5): 264–269.
9.  [↑](#cite_ref-9) Shyu, K., Wang, B., Yang, Y., Tsai, S., Lin, S., Lee, C. (1 July 2004). ["Amphetamine activates connexin43 gene expression in cultured neonatal rat cardiomyocytes through JNK and AP-1 pathway"](https://academic.oup.com/cardiovascres/article-lookup/doi/10.1016/j.cardiores.2004.02.018). *Cardiovascular Research*. **63** (1): 98–108.
10. [↑](#cite_ref-10) Bazmi, E., Mousavi, F., Giahchin, L., Mokhtari, T., Behnoush, B. (30 March 2017). ["Cardiovascular Complications of Acute Amphetamine Abuse: Cross-sectional study"](https://journals.squ.edu.om/index.php/squmj/article/viewFile/1813/1763). *Sultan Qaboos University Medical Journal*. **17** (1): e31–37.
11. [↑](#cite_ref-11) Jacobs, W. (June 2006). ["Fatal Amphetamine-Associated Cardiotoxicity and Its Medicolegal Implications:"](http://journals.lww.com/00000433-200606000-00012). *The American Journal of Forensic Medicine and Pathology*. **27** (2): 156–160.
12. [↑](#cite_ref-12) Won, S., Hong, R. A., Shohet, R. V., Seto, T. B., Parikh, N. I. (December 2013). ["Methamphetamine-Associated Cardiomyopathy: Methamphetamine-associated cardiomyopathy"](https://onlinelibrary.wiley.com/doi/10.1002/clc.22195). *Clinical Cardiology*. **36** (12): 737–742.
13. ↑ [13.0](#cite_ref-:0_13-0) [13.1](#cite_ref-:0_13-1) [13.2](#cite_ref-:0_13-2) Frishman, W. H., Del Vecchio, A., Sanal, S., Ismail, A. (July 2003). ["Cardiovascular Manifestations of Substance Abuse: Part 2: Alcohol, Amphetamines, Heroin, Cannabis, and Caffeine"](http://journals.lww.com/00132580-200307000-00003). *Heart Disease*. **5** (4): 253–271.
14. [↑](#cite_ref-14) Behzadi, M., Joukar, S., Beik, A. (2018). ["Opioids and Cardiac Arrhythmia: A Literature Review"](https://www.karger.com/Article/FullText/492616). *Medical Principles and Practice*. **27** (5): 401–414.
15. [↑](#cite_ref-15) Doshi, R., Shah, J., Desai, R., Gullapalli, N. (July 2019). ["Burden of arrhythmia in hospitalizations with opioid overdose"](https://linkinghub.elsevier.com/retrieve/pii/S016752731837284X). *International Journal of Cardiology*. **286**: 73–75.